Atlas Trials

FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal Cancer

Clinical trial NCT00323011 · TERMINATED

Trial details

NCT number
NCT00323011
Sponsor
University of Southern California
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Cancer
Start date
2006-05-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.